Jupiter Wellness, Inc.: directors' dealings · United States · SEC (Form 4)

About Jupiter Wellness, Inc.

Jupiter Wellness, Inc. is a U.S.-based company listed on NASDAQ in the United States. Incorporated in Delaware in 2018, the company originally focused on CBD-based wellness and skin-care products and later repositioned itself toward a broader dermatology and consumer health platform. Its principal operating presence is in Jupiter, Florida, giving it a clearly domestic U.S. footprint even as it markets products and develops its brand around topical wellness and skin-health applications. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315222008220/form10-k.htm?utm_source=openai)) From a business perspective, Jupiter Wellness has been organized around the development, manufacturing, and commercialization of skin, hair, and sexual wellness products, alongside selected therapeutic programs. SEC disclosures describe a pipeline that has included topical concepts for eczema, dermatitis, actinic keratosis, cold-sore symptoms, and burn-related care, as well as consumer wellness offerings. The company has also referenced proprietary OTC brands, including sunscreen and other wellness products distributed through its e-commerce channels. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315223010480/form10-k.htm?utm_source=openai)) Competitively, Jupiter Wellness operates in a highly fragmented category where product differentiation depends on formulation quality, scientific credibility, regulatory execution, and go-to-market effectiveness. The company has described its strategy as science- and research-driven, aiming to move beyond the commoditized CBD narrative and build a more defensible portfolio in topical therapeutics and wellness. That said, it remains a small-cap, development-stage name rather than an established large-cap healthcare franchise, so its market position should be viewed as opportunistic and higher risk, with upside tied to product adoption and commercialization progress. ([nasdaq.com](https://www.nasdaq.com/press-release/it-all-comes-down-to-science-and-research-with-the-efficacy-of-jupiter-wellnesss?utm_source=openai)) Recent developments have included strategic repositioning, capital raises, and other balance-sheet related actions, including a PIPE transaction disclosed in 2023. More recently filed SEC documents also highlight going-concern risk, which is a key consideration for equity investors assessing liquidity, dilution risk, and execution uncertainty. For investors following insider activity, Form 4 filings can provide useful signals, but in Jupiter Wellness’s case they should be read in the context of a company still navigating a turnaround-style development phase. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1760903/000149315223010480/form10-k.htm?utm_source=openai))